13-ETHYL-17-HYDROXY-18,19-DINORPREGN-20-YN-3-ONE, (5.ALPHA.,17.ALPHA.)-(+/-)-
UNII V4GH2U8LH2
Substance Identification & Data
This profile provides standardized clinical and technical data for 13-ethyl-17-hydroxy-18,19-dinorpregn-20-yn-3-one, (5.alpha.,17.alpha.)-(+/-)-, uniquely identified by the FDA Unique Ingredient Identifier (UNII) V4GH2U8LH2.
Technical mappings include the Chemical Abstracts Service (CAS) Registry Number 20402-55-5 and the RxNorm Concept ID (RxCUI) N/A. Explore the sections below for detailed nomenclature and a complete directory of NDC-listed products containing this ingredient.
Detailed Substance Profile
C21H30O2 BMVIRDJAPBCAPQ-WQGSDSCCSA-N;BMVIRDJAPBCAPQ-HVZDBWIMSA-N Synonyms and Nomenclature
This section provides a complete list of nomenclature and identifier mappings for 13-ethyl-17-hydroxy-18,19-dinorpregn-20-yn-3-one, (5.alpha.,17.alpha.)-(+/-)-. Identifiers are organized into official regulatory terms, commercial trade names, and technical systematic synonyms used to ensure accurate identification across clinical pharmaceutical databases, regulatory filings, and electronic health records.